But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.

The commercials make it sound so simple: "If it's COVID, Paxlovid." But the slogan, catchy though it may be, belies a harsher reality that some public health and elected officials have long ...

A recent investigation documented the experiences of 13 long COVID patients who tried taking Paxlovid for longer than the typical 5-day course. The patients had mixed results, adding to a growing body ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...

A large-scale study reveals azvudine’s comparable efficacy to Paxlovid, fewer adverse effects, and potential antitumor benefits in patients with liver cancer. Study: Real‐world effectiveness ...

It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older ...

Paxlovid use was associated with lower rates of hospitalization and death, particularly among older adults, a new study finds. The study published in PLOS Medicine on Jan. 17 found that Paxlovid ...

What to avoid with this at-home COVID-19 treatment Paxlovid is a combination antiviral medication that contains nirmatrelvir ...

He was hopeful that he was starting to recover. This was now Saturday afternoon so calling my doctor to get the antiviral drug Paxlovid meant reaching the answering service and having them contact ...

What do you do? Specifically, what's the role of antivirals? You might have heard about a drug called Paxlovid. Well, Paxlovid is a pill that you take by mouth, as opposed to some other therapies ...

One of the medications to be affected includes Paxlovid, a treatment for COVID-19. The price hikes will also affect costs for Bristol Myers Squibb’s cancer cell therapies Abecma and Breyanzi as ...

Can Paxlovid treat long COVID? A new report suggests it might help some patients, but which patients might benefit remains unclear. The report, published last week in the journal Communications ...